Skip to Main Content

Paper Details

Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.
Cell Rep
54
2018
CCND1, CDK4, CDK4and, CDK6, CDKN2A, G1/, HNSCC, Head and Neck Squamous Cell Carcinoma, PDX, PDX models, PDXs, Patient, S, abemaciclib, cancers, head and neck squamous cell carcinoma, mice, patient, patients, tumor
Author NameAffiliation
Jeff P BrucePrincess Margaret Cancer Centre, University Health Network
Jalna MeensPrincess Margaret Cancer Centre, University Health Network
Shao Hui HuangPrincess Margaret Cancer Centre, University of Toronto
David P GoldsteinPrincess Margaret Cancer Centre, Canada University of Toronto
Ilan WeinrebUniversity Health Network
Brian O'SullivanPrincess Margaret Cancer Centre, University of Toronto
Fei-Fei LiuPrincess Margaret Cancer Centre, University of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Wei XuPrincess Margaret Cancer Centre, University Health Network
Laurie AillesPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 11

Datasets

Release 1.2